Crinetics Pharmaceuticals's total assets for Q3 2025 were $1.20B, a decrease of -7.25% from the previous quarter. CRNX total liabilities were $123.86M for the fiscal quarter, a 4.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.